Biostar Pharmaceuticals, Inc. (BSPM)

[bbarry]

a flaw in interpreting the aging A/R trend here. The fact that each of the older 30 day periods has lower total A/R outstanding can't be used to interpet a recent month by month growth in total sales. You don't want to assume that the totals reported for the 30-60 and 60-90 aged periods represents ALL sales for those respective periods. Presumably some receivables have come in during those older periods. Hence, those reported A/R figures are NOT the total sales for each of those older periods.

Overall, the rest of the ER looks very encouraging.

otherwise, thanks Fernando for your many many helpful posts on various stocks.

Barry